Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0001209191-19-056372

Director sold 7,500 shares at $55.00 ($412,500)

  • Director acquired 7,500 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
CAGNONI PABLO J Director 2019-11-12 Option exercise +7,500 $5.59 $41,925 7,500 D
CAGNONI PABLO J Director 2019-11-12 Sale −7,500 $55.00 $412,500 0 D
Derivatives
CAGNONI PABLO J Director 2019-11-12 Option exercise · Stock Option (Right to Buy) −7,500 71,333 D
Open-market sales · 7,500 sh · avg $55.00 · $412,500
Loading xslF345X03/doc4.xml…